Detalhe da pesquisa
1.
Prevention of antimicrobial prescribing among infants following maternal vaccination against respiratory syncytial virus.
Proc Natl Acad Sci U S A
; 119(12): e2112410119, 2022 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35286196
2.
A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age.
J Infect Dis
; 213(3): 411-22, 2016 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26259809
3.
Validation of a severe acute respiratory syndrome coronavirus 2 microneutralization assay for evaluation of vaccine immunogenicity.
J Virol Methods
; 327: 114945, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38649070
4.
A recombinant viruslike particle influenza A (H7N9) vaccine.
N Engl J Med
; 369(26): 2564-6, 2013 Dec 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-24224560
5.
A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age.
Vaccine
; 35(30): 3749-3759, 2017 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28579233
6.
Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers.
Clin Infect Dis
; 41(8): 1114-22, 2005 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16163629
7.
Modeling maternal fetal RSV F vaccine induced antibody transfer in guinea pigs.
Vaccine
; 33(47): 6488-92, 2015 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-26319066
8.
An insect cell derived respiratory syncytial virus (RSV) F nanoparticle vaccine induces antigenic site II antibodies and protects against RSV challenge in cotton rats by active and passive immunization.
Vaccine
; 32(48): 6485-92, 2014 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-25269094
9.
Safety of AS03-adjuvanted inactivated split virion A(H1N1)pdm09 and H5N1 influenza virus vaccines administered to adults: pooled analysis of 28 clinical trials.
Hum Vaccin Immunother
; 10(10): 2942-57, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25483467
10.
Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.
Vaccine
; 31(40): 4305-13, 2013 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-23891795